OncoMed Pharmaceuticals Inc. Company Profile | StatInvestor

Health Care & Life Sciences » Biotechnology | OncoMed Pharmaceuticals Inc.

OncoMed Pharmaceuticals Inc.

OncoMed Pharmaceuticals Inc.
Stock Exchange	Frankfurt Stock Exchange
EPS	-
Market Cap	-
Shares Outstanding	38.5 M
Public Float	28.42 M

OncoMed Pharmaceuticals Inc.
Stock Exchange	NASDAQ Stock Market
EPS	$0.28
Market Cap	$103.96 M
Shares Outstanding	38.5 M
Public Float	25.73 M

Profile

Address	800 Chesapeake Drive Redwood City California 94063 United States
Employees	-
Website	http://www.oncomed.com
Updated	09/14/2018
OncoMed Pharmaceuticals, Inc. operates as a clinical stage biopharmaceutical company, which focuses on discovering and developing novel therapeutics for cancer's growth, resistance, recurrence and metastasis. The company was founded by Michael F. Clarke and Max Wicha in August 2004 and is headquartered in Redwood City, CA.

Financials

Perry A. Karsen

Executive Chairman

John A. Lewicki

President, Chief Executive Officer & Director